1. Medtech Insight
  2. >>Geography
  3. >>Europe

MedTech Europe Appeals To Re-elected Von Der Leyen To Address MDR/IVDR Problems

 
• By Amanda Maxwell

Early and comprehensive reform of the MDR and IVDR is critical to address overregulation and unpredictable medtech regulatory processes, medtech tells reelected Commission President.

“Seven years after their publication, the Medical Devices and In Vitro Diagnostic Medical Devices Regulations continue to hamper access to lifesaving and life-sustaining medical technologies as they are plagued by inefficient and unpredictable processes, skyrocketing cost of compliance, insufficient support for innovation and a lack of accountable governance.”

Strong words from industry association MedTech Europe in a statement responding to news that Ursula von der Leyen has been...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

More from Geography

EU Pilot Features ‘All-In-One’ Regulatory Path For Drug/Diagnostic Trials

 
• By Vibha Sharma

The EU is testing a groundbreaking “all-in-one” process for reviewing combined drug and diagnostic trials via a single application for coordinated assessment.

European Medtechs Reiterate Opposition To Reciprocal Tariffs On US Imports

 
• By Ashley Yeo

EU countermeasures against US tariffs suggest medtech categories exported to the EU could be targeted for tariffs. MedTech Europe and the German IVDs industry have stressed the negative effects this would have on patient care.

Ceryx Medical Amasses £11M To Develop Adaptive Cardiac Pacing Technology

 
• By Natasha Barrow

The Development Bank of Wales and London-based Parkwalk Advisors led an investment round of £5m, almost doubling Ceryx Medical's total investment to date.